CIK 0001527753
- Non-accelerated filer
- Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275411038
- Phone
- +1 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- 4 Grant or award CFO AND COO acquired 34,375 shares (grant or award)
- 4 Grant or award SVP and Chief Legal Officer acquired 28,125 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 87,500 shares (grant or award)
- 4 Grant or award President and CMO acquired 46,875 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 320,267 shares at an average $8.55 ($2,739,181)
- 4 Planned sale CFO AND COO sold 1,201 shares at $11.50 ($13,812)
- 4 Planned sale CFO AND COO sold 103,668 shares at $10.78 ($1,117,541)
- 4 Open-market sale PRESIDENT AND CEO sold 29,612 shares at $8.99 ($266,212)
- 4 Open-market sale CHIEF MEDICAL OFFICER AND EVP sold 452 shares at $6.57 ($2,970)
- 4 Open-market sale CFO AND COO sold 641 shares at $6.57 ($4,211)
- 4 Open-market sale CFO AND COO sold 1,291 shares at $4.95 ($6,390)
- 4 Open-market sale SVP and Chief Legal Officer sold 1,675 shares at $4.95 ($8,291)
- 4 Open-market sale CHIEF MEDICAL OFFICER AND EVP sold 910 shares at $4.95 ($4,505)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 15 · 289 filings